Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence-Reference-Cited by-同舟云学术

Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence

Published:2011-06-15 Issue:11 Volume:91 Page:1173-1176
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Schnitzbauer Andreas A.,Schlitt Hans J.,Geissler Edward K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference22 articles.

1. Cancer after kidney transplantation in the United States.;Kasiske;Am J Transplant,2004

2. mTOR, cancer and transplantation.;Geissler;Am J Transplant,2008

3. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor.;Guba;Nat Med,2002

4. Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.;Lang;Hepatology,2009

5. Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: A phase 2 trial in the North Central Cancer Treatment Group.;Ansell;Cancer,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Sirolimus to treat chronic and steroid‐resistant allograft rejection‐related fibrosis in pediatric liver transplantation;Journal of Pediatric Gastroenterology and Nutrition;2024-07-08

3. Immunosuppressive Medication Adherence in Patients With Hepatocellular Cancer Who Have Undergo Liver Transplantation: A Case Control Study;Transplantation Proceedings;2023-06

4. Does mTORi base immunosuppression offer survival advantage after liver transplantation for hepatocellular carcinoma? Systematic review and meta-analysis of randomized controlled trials;Hepatology Forum;2023

5. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation;Journal of Clinical Medicine;2022-07-28